Home›Stock Screener›Unichem Laboratories›Quarterly Results

Unichem Laboratories Quarterly Results

Latest Quarter Net Profit
₹11 Cr
QMar 2026
Quarterly Results

Unichem Laboratories quarterly results. In Mar 2026, Unichem Laboratories (UNICHEMLAB) reported revenue ₹599 Cr and net profit ₹11 Cr — revenue +0.5% YoY. For annual financials, live price and key ratios, visit UNICHEMLAB stock price BSE.

UNICHEMLAB Quarterly Results — Revenue, Profit & EPS Highlights

Unichem Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review UNICHEMLAB P/E comparison to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹599 Cr in Mar 2026 (-7.6% vs Jun 2026, +0.5% vs Mar 2025)
  • Net Profit of ₹11 Cr in Mar 2026 (-73.8% vs Jun 2026, -79.2% vs Mar 2025)
  • EBITDA of ₹59 Cr in Mar 2026 (-31.4% vs Jun 2026)
  • Operating Margin of 6.0% in Mar 2026 (-5.0pp vs Jun 2026)
  • Earnings Per Share of ₹1.55 in Mar 2026 (-73.7% vs Jun 2026)

Unichem Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

UNICHEMLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 599 648 600 596 533 -7.6% 0.5%
Net Profit (₹ Cr) 11 42 -12 53 -11 - -
EBITDA (₹ Cr) 59 86 29 93 29 - -
EPS (₹) 1.55 5.89 -1.69 7.52 -1.49 - -
Operating Margin (%) 6.0% 11.0% 1.0% 14.0% 4.0% - -

UNICHEMLAB Share Price Trend — 1-Year Movement Across Quarterly Results

Unichem Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Unichem Laboratories networth to track the company's total market size over time.

Profitability Ratios

Profit Margin 1.8%
EBITDA Margin 9.8%
Operating Margin 6.0%
ROE (Annual) 1.6%

Balance Sheet Highlights

Total Assets ₹3,737 Cr
Total Equity ₹2,717 Cr
Current Assets ₹2,197 Cr
Current Liabilities ₹134 Cr

Cash Flow Analysis

Operating Cash Flow ₹4 Cr
Investing Cash Flow ₹194 Cr
Financing Cash Flow ₹2 Cr
Net Cash Flow ₹200 Cr

Current Market Data

Current Price ₹531.45
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 596
Sept 2025 600
Jun 2026 648
Mar 2026 599

Net Profit Trend (₹ Cr)

Mar 2025 53
Sept 2025 -12
Jun 2026 42
Mar 2026 11

Operating Margin Trend (%)

Mar 2025 14.0%
Sept 2025 1.0%
Jun 2026 11.0%
Mar 2026 6.0%

UNICHEMLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Unichem Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores